Bhutan vs Bulgaria: Access to anti-retroviral drugs, male
Bhutan
62.0%
in 2024
Bulgaria
63.0%
in 2024
Bhutan rank
94th
Bulgaria rank
92nd
Access to anti-retroviral drugs, male over time
- Bhutan
- Bulgaria
How they compare
Bulgaria currently reports 63.0% against 62.0% in Bhutan, a difference of 1.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Bulgaria ahead.
Bhutan ranks 94th and Bulgaria ranks 92nd of 141 countries.
Across the 3 decades both report, Bhutan averaged higher in 1 and Bulgaria in 2.
Head to head by decade
| Decade | Bhutan | Bulgaria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.9% | 8.6% | 5.7% | Bulgaria |
| 2010s | 33.6% | 33.2% | 0.4% | Bhutan |
| 2020s | 58.0% | 60.4% | 2.4% | Bulgaria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Bhutan or Bulgaria?
- Bulgaria, at 63.0% against 62.0% in Bhutan as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Bhutan and Bulgaria?
- 1.0%, with Bulgaria ahead.
- How many years of comparable data are there for Bhutan and Bulgaria?
- 25 years are reported by both, from 2000 to 2024.
- How do Bhutan and Bulgaria rank globally for access to anti-retroviral drugs, male?
- Bhutan ranks 94th and Bulgaria ranks 92nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.